Novo Nordisk thrives despite competition and explore its breakthrough amycretin study. Read here to know why we rate NVO ...

We recently published a list of Renaissance Technologies Portfolio: Top 10 Stock Picks. In this article, we are going to take ...

Weight-loss drugs aren’t just slimming waists; they create a $100 billion market opportunity. With plenty up for grabs, ...

Fuse Vectors has raised $5.2 million of funding as it moves closer to commercialising its innovative new approach to ...

The NNF – a philanthropic non-profit organisation that owns a controlling stake in Danish drugmaker Novo Nordisk – said ... of Copenhagen with support from Denmark’s Statens Serum Institut ...

SNIPR BIOME ApS (“SNIPR” or “the Company”), a clinical stage biotech company pioneering CRISPR-based therapies, today announces grant of patent EP4392563B on February 24th 2025 by the European Patent ...

According to Statistik Denmark’s annual report, Denmark’s GDP increased by 3.6% in 2024. The growth in the fourth quarter was 1.6% when adjusted for price changes and seasonal fluctuations. The ...

Dansk Retursystem, a non-profit organization which oversees the deposit system in Denmark, reports that 99% of plastic bottles are now returned with their lids on, following the EU directive requiring ...

reNEW, the Novo Nordisk Foundation Center for Stem Cell Medicine, was launched in January 2022 and it supports stem cell research across three international sites in Denmark, Australia ...

Zealand’s CEO Adam Steensberg said that the company is “exactly where it wants to be” in terms of its partnering and ...

Novo Nordisk ( NVO 5.29%) stock ran up 3.5% through 10:05 a.m. ET Friday morning on some good news for it (and for Eli Lilly ...